Anna J Langerveld, PhD

Anna J Langerveld, PhD
Anna J Langerveld, PhD

Research Assistant Professor, Department of Biomedical Sciences


Contact Information

Email:

Biosketch

Anna Langerveld, PhD, is President and CEO of Genemarkers LLC, a company that provides collaborative services that enhance the utilization of genomics for improving health care, pharmaceutical research and consumer products. Dr. Langerveld is a graduate of SUNY - Binghamton in Binghamton, New York. She earned her doctorate in neuroscience from Tulane University in New Orleans, Louisiana.

Dr. Langerveld is an active researcher and presenter in the field of genomics. Her company has worked in conjunction with other companies applying genomics to the fields of animal health, personal care products, and molecular diagnostics.

Dr. Langerveld serves on the advisory board of the pharmacogenomics program of Manchester University, the first program to offer a one-year master's degree in pharmacogenomics.

  • 汤头条app and Training

    • PhD 1998, Neuroscience, Tulane University
    • BA 1989, Biochemistry, State University of New York at Binghamton
  • Research

    • Neuroscience
  • Publications

    • Bright D.R., Klepser D., Langerveld A. Research in Social and Administrative Pharmacy. 2024;20:152-155.

    • DeHaven C., Wheeler S., Langerveld A., Johns C.B. Regulation of dermal circadian pathways by a novel topical formulation International Journal of Cosmetic Science. 2024

    • Beam T.A., Klepser D.G., Klepser M.E., Bright D.R., Klepser N., Schuring H., Wheeler S., Langerveld A. Research in Social and Administrative Pharmacy. 2023;19:1360-1364.

    • Kala R., Heiberger N., Mallin H., Wheeler S., Langerveld A. International Journal of Cosmetic Science. 2023;45:95-107.

    • Bright D., Langerveld A., DeVuyst-Miller S., Saadeh C., Choker A., Lehigh E., Wheeler S., Zayzafoon A., Sohn M. Pharmacogenomics Journal. 2021;21:326-335.

    • Bright D., Saadeh C., Devuyst-Miller S., Sohn M., Choker A., Langerveld A. Pharmacist consult reports to support pharmacogenomics report interpretation Pharmacogenomics and Personalized Medicine. 2020;13:719-724.

    • Bright D.R., Greco A.J., Langerveld A., Kisor D.F. Personalized Medicine. 2017;14(6):471-475.

    • Langerveld A., Schnarr P., Suarez M., Jarrett J.C., Conaghan J., Rosa G.J.M., Fern谩ndez E., Rawlins R.G., Cibelli J.B., Crosby J.A. Fertility and Sterility. 2013;99(3)

    • Langerveld A.J., Celestine R., Zaya R., Mihalko D., Ide C.F. Environmental Research. 2009;109(4):379-389.

    • Langerveld A., Mihalko D., DeLong C., Walburn J., Ide C.F. Movement Disorders. 2007;22(6):766-777.

    • Katbamna B., Langerveld A., Ide C.F. Journal of Comparative Physiology A: Neuroethology, Sensory, Neural, and Behavioral Physiology. 2006;192(9):971-983.

    • Lehigh Shirey E., Jelaso Langerveld A., Mihalko D., Ide C. Environmental Research. 2006;102(2):205-214.